Genzyme Europe B.V.
Developing transformative therapies
- B2B
About Genzyme Europe B.V.
A pioneering biotech company committed to developing transformative therapies for rare genetic diseases, thyroid cancer, and multiple sclerosis, prioritizing patient needs
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Naarden, North Holland, Netherlands
- Founded
- 1981
- Revenue
- $20.5M – $162MTamtam estimate
Genzyme Europe B.V. at a glance
Genzyme Europe B.V. is a B2B company in the Biotechnology Research industry, headquartered in Naarden, North Holland, Netherlands.
Genzyme Europe B.V. was founded in 1981.
Genzyme Europe B.V. has 251–1,000 employees.
Genzyme Europe B.V.'s revenue is $20.5M – $162M (Tamtam estimate).
Frequently asked questions about Genzyme Europe B.V.
What is Genzyme Europe B.V.'s revenue?
Tamtam estimates Genzyme Europe B.V.'s annual revenue at $20.5M – $162M.
How many employees does Genzyme Europe B.V. have?
Genzyme Europe B.V. has 251–1,000 employees.
Where is Genzyme Europe B.V. headquartered?
Genzyme Europe B.V. is headquartered in Naarden, North Holland, Netherlands.
Selling to companies like Genzyme Europe B.V.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies